Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target by Fundamental Research Analysts

Fundamental Research set a $13.87 target price on Zepp Health (NYSE:ZEPP) in a research note published on Tuesday,BayStreet.CA reports. The firm currently has a buy rating on the stock.

Zepp Health Price Performance

NYSE ZEPP opened at $2.18 on Tuesday. Zepp Health has a 12-month low of $2.06 and a 12-month high of $4.38. The firm’s fifty day simple moving average is $2.93 and its two-hundred day simple moving average is $3.06. The company has a current ratio of 1.21, a quick ratio of 0.87 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $32.81 million, a P/E ratio of -0.87 and a beta of 0.71.

Hedge Funds Weigh In On Zepp Health

An institutional investor recently bought a new position in Zepp Health stock. Virtu Financial LLC purchased a new position in shares of Zepp Health Co. (NYSE:ZEPP) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned 0.09% of Zepp Health as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.